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Purpose: To report a case of a 25-year-old woman with previously treated peripheral T-cell 
lymphoma (PTCL) presenting with a recurrent lower eyelid lesion.
Patients and method: Case report.
Results: A 25-year-old young woman with previously treated PTCL noted an induration in the 
skin of her left lower eyelid. Upon diagnosis of a chalazion, antibiotic eye drops and ointments 
as well as steroid eye drops were administered. However, the condition worsened rapidly 
and swelling of the lower eyelid became remarkable. An excisional biopsy revealed that the 
palpebral lesion was diagnosed as recurrence of PTCL. Electron irradiation was applied as a 
radical treatment, and the prognosis was satisfactory without recurrence at 10 months after the 
last irradiation.
Conclusions: Although lymphoma isolated to the ocular adnexa is rare, it should always be 
included in the differential diagnosis of any patient presenting with progressive swelling of the 
eyelid or ocular region.
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Introduction
Peripheral T-cell lymphoma (PTCL) represents a broad spectrum of disease with 
several different manifestations. PTCL often occurs in the extremities, but rarely in 
the eyelid. Periocular involvement by PTCL usually occurs in the setting of the Sézary 
syndrome or mycosis fungoides, which is a variant of PTCL.1–4 We report a case of 
a 25-year-old young woman with previously treated PTCL presenting with a recurrent 
lower eyelid lesion.
Case report
The patient’s history dates back to 2006 when she had multiple skin lesions that were 
diagnosed as PTCL and subsequently excised. Submandibular and parotid lymph nodes 
were palpable, but there was no swelling of the liver or spleen. Blood tests were negative 
for adult T-cell leukemia antibody and human immunodeficiency virus (HIV) antibody 
and soluble interleukin-2 receptor was within normal range. No other lesion was 
detected by gallium scintigraphy or systemic computed tomography. A bone marrow 
trephine biopsy did not show the involvement of lymphoma. Immunostaining revealed 
the cells to be positive for CD3 and CD5, but negative for CD30, CD10, and CD75. 
Based on the findings, the patient was classified as PTCL Stage IVB according to the 
new World Health Organization classification.5 As the patient was chemorefractory Clinical Ophthalmology 2009:3 528
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against initial treatment with combined cyclophosphamide, 
deoxorubicin, vincristine, and prednisone, she underwent 
allogenic stem cell transplantation from a matched non-
sibling donor in March 2007 after salvage treatment with 
cyclophosphamide, cytosine arabinoside, etoposide, and 
dexamethasone. Transplant-conditioning therapy was cyclo-
phosphamide, 2900 mg/day for three days, plus total body 
irradiation for three days (total 12 Gy). Graft-versus-host 
disease prophylaxis was provided with cyclosporine A and 
prednisolone. Cyclosporin levels were maintained between 
300 and 400 µg/L until tapering was initiated. Initial dose 
of prednisolone was 17.5 mg per oral.
In January 2008, the patient presented to our department 
to check for any ocular manifestations of the graft-versus-host 
disease. At that time, significant superficial punctate 
keratopathy was noted in both eyes. Systemic skin and eyelids 
were macroscopically normal. Systemic lymph nodes were 
not palpable, and there was no swelling of the liver or spleen. 
The superficial punctate keratopathy significantly improved 
with eyedrops containing hyaluronan.
On July 11, 2008, the patient noted an induration in the 
skin of her left lower eyelid (Figures 1A, B). Conjunctival 
congestion and pain were present. Upon diagnosis of an acute 
chalazion, conservative management was used. However, the 
condition worsened rapidly, and swelling of the lower eyelid 
became remarkable (Figures 1C, D).
On August  25,  2009,  the  patient  underwent  an 
excisional biopsy of the palpebral lesion after informed 
consent. A retention cyst in chalazion was not detected during 
the intraoperative microscopic examination. Pathological 
examination demonstrated that medium-sized lymphoma 
cells with round nuclei (Figures 2A, B) had infiltrated 
subcutaneously. Immunostaining revealed the cells to be 
positive for CD3 (Figures 2C). Considering these results, the 
palpebral lesion was diagnosed as recurrence of PTCL.
As the lesion was limited to the left lower eyelid, 25.2 Gy 
electron irradiation was applied as a radical treatment. Globe 
shielding was used to help prevent radiation retinopathy. The 
eyelid tumor was dramatically improved after irradiation 
(Figures 2D, 2E). The prognosis was satisfactory without 
recurrence at 10 months after the last irradiation.
Discussion
Ocular manifestations of PTCL can include both intraocular 
and extraocular conditions.1–4 Cook and colleagues6 reported 
that eyelid ectropion was the most common findings in their 
patients with PTCL, though other ocular manifestations, 
including eyelid thickening or edema, placoid tumor, tight 
skin, blepharitis, and corneal abnormalities, were also found. 
Stenson and Ramsay7 found eyelid tumors in eight of 30 
consecutive patients with mycosis fungoides diagnosed by 
biopsy. Isolated PTCL of the eyelid is rare.8,9 Gilbertson 
and colleagues1 reported a case of a 38-year-old acquired 
immunodeficiency syndrome (AIDS) patient with isolated 
eyelid PTCL, and found only eight previous reports of 
isolated PTCL, most diagnosed as mycosis fungoides. In this 
type of lymphoma, relapses are common and can produce 
an indolent course. Kirsch and colleagues reported a patient 
with multiple recurrences of systemic T-cell lymphoma after 
initial presentation with only an eyelid mass that was treated 
with systemic chemotherapy and local radiation.4
The present case was a single episode of lymphoma of 
the eyelid with clinical symptoms resembling a chalazion. 
However, an excisional biopsy of the current lesion con-
firmed the recurrence of the actual tumor and so ruled out 
a chalazion. The current case still requires close follow-up 
observation, particularly of the skin around the lesion. When 
radiation therapy is used for eyelid lesions, great care must 
be taken with ocular side effects, including xerophthalmia 
and radiation retinopathy.6 Although lymphoma isolated to 
the ocular adnexa is rare, it should always be included in the 
differential diagnosis of any patient presenting with progres-
sive swelling of the eyelid or ocular region, particularly with 
a history of lymphoma.
Figure 1 A) Patient with chalazion-like induration of the left lower eyelid on July 11, 
2008. B) High magnification of the lower eyelid with chalazion-like presentation. 
C) After one month, induration of the lower eyelid became rapidly enlarged. Note a 
diffuse, erythematous, thickened lower eyelid. D) High magnification of the thickened 
lower eyelid.Clinical Ophthalmology 2009:3
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Figure 2 A) Light micrograph of hematoxylin and eosin stained eyelid biopsy specimen. Lymphoma cells were infiltrated into the subcutaneous tissue. P, palpebral skin; 
Bar = 200 µm. B) High magnification of the lymphoma cells infiltrated in the orbicular muscles (arrows). Bar = 100 µm. C) Light micrograph of eyelid biopsy specimen immu-
nostained with CD3 antibody. CD3 positive lymphoma cells were distributed in the subcutaneous tissue. Bar = 100 µm. Photographs of eyelids before D) and after irradiation 
E) The eyelid tumor was dramatically improved after irradiation.